Findings from Belgian Nuclear Research Centre (SCK-CEN) Provides New Data about Pharmaceutics (Exploring the Potential of High-molar-activity Samarium-153 for Targeted Radionuclide Therapy With [Sm-153]Sm-dota-tate)

Presse/Médias: Commentaire d'expert

période15 févr. 2023

Couverture médiatique

1

Couverture médiatique

  • titreFindings from Belgian Nuclear Research Centre (SCK-CEN) Provides New Data about Pharmaceutics (Exploring the Potential of High-molar-activity Samarium-153 for Targeted Radionuclide Therapy With [Sm-153]Sm-dota-tate)
    Media name / outletNewsRx Drug Daily
    Pays/TerritoireÉtats-Unis
    la date15/02/23
    PersonnesNoami DAEMS
Voir tout 1
Voir moins